ALLCOVID-19PatentsTrade PolicyTRIPS Book Launch: Intellectual Property Law and Access to Medicines: TRIPS Agreement, Health and PharmaceuticalsNovember 18, 2021 Online Conference - November 23, 2021 13:00 - 17:00 GMT 7:00 - 11:00 am U.S.…Michael Palmedo COVID-19Data ExclusivitiesTrade Policy Promotion of TRIPS-Plus Intellectual Property Provisions Through the Special 301 Review: How Did It Change During the COVID-19 Pandemic?August 17, 2021 This post introduces my chapter the Special 301 Report in the newly-published book Intellectual Property…Michael Palmedo COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Michael PalmedoSrividhya Ragavan Search Search Blog Front Page CategoriesCategories Select Category ALL (1) Conferences and Papers (1) COVID-19 (26) Data Exclusivities (5) Deceptive Claims (1) Exhaustion (2) Experimental Use (1) IPAB (1) Patent Pools (2) Patents (18) Right to Health (5) TAMU (1) Trade Policy (6) TRIPS (24) TRIPS Flexibilities (6) Vaccines (6) Voluntary Licenses (1) Archives Archives Select Month July 2022 June 2022 March 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 May 2021 February 2021 January 2021 December 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 Regular Contributors Doris Estelle Long (13) Srividhya Ragavan (12) Shirin Syed (4) Michael Palmedo (3) Jonathan Kimball (1) Sonal Singh (1) All Authors RECENT POSTS Call For Papers: The Eighth Annual IP Mosaic Conference Working with the Ministerial Decision on TRIPS Ministerial Decision: “TRIPped” the Waiver? Intellectual Property Law and Access to Medicines Named One of the Best New Intellectual Property Books by BookAuthority Omicron: Requires TRIPS Waiver Vaccine
COVID-19Data ExclusivitiesTrade Policy Promotion of TRIPS-Plus Intellectual Property Provisions Through the Special 301 Review: How Did It Change During the COVID-19 Pandemic?August 17, 2021 This post introduces my chapter the Special 301 Report in the newly-published book Intellectual Property…Michael Palmedo COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Michael PalmedoSrividhya Ragavan Search Search Blog Front Page CategoriesCategories Select Category ALL (1) Conferences and Papers (1) COVID-19 (26) Data Exclusivities (5) Deceptive Claims (1) Exhaustion (2) Experimental Use (1) IPAB (1) Patent Pools (2) Patents (18) Right to Health (5) TAMU (1) Trade Policy (6) TRIPS (24) TRIPS Flexibilities (6) Vaccines (6) Voluntary Licenses (1) Archives Archives Select Month July 2022 June 2022 March 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 May 2021 February 2021 January 2021 December 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 Regular Contributors Doris Estelle Long (13) Srividhya Ragavan (12) Shirin Syed (4) Michael Palmedo (3) Jonathan Kimball (1) Sonal Singh (1) All Authors RECENT POSTS Call For Papers: The Eighth Annual IP Mosaic Conference Working with the Ministerial Decision on TRIPS Ministerial Decision: “TRIPped” the Waiver? Intellectual Property Law and Access to Medicines Named One of the Best New Intellectual Property Books by BookAuthority Omicron: Requires TRIPS Waiver Vaccine
COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Michael PalmedoSrividhya Ragavan
